Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Michael Shepard

Showing results (21-30 of 33) with videos related to

Pageof 4
Sort By:
Molecular Cancer Therapeutics|October 28, 2010
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal modelsCurtis B Thompson, H Michael Shepard, Patrick M O'Connor, et al.
British Journal of Cancer|January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Oncotarget|November 26, 2019
The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44Chunmei Zhao, Benjamin J Thompson, Kelly Chen, et al.
British Journal of Cancer|September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Biomed Research International|August 23, 2014
Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironmentAnne Kultti, Chunmei Zhao, Netai C Singha, et al.
Molecular Cancer Therapeutics|October 15, 2008
Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenograftsJay Sarup, Pei Jin, Lisa Turin, et al.
JCI Insight|November 2, 2019
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cellYanran He, Karin Schreiber, Steven P Wolf, et al.
Biophysical Journal|May 12, 2016
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid PhaseChristopher C DuFort, Kathleen E DelGiorno, Markus A Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic CancerSunil R Hingorani, William P Harris, J Thaddeus Beck, et al.
Immunology|August 20, 2022
Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosisBao Ying Chen, Jessica R Salas, Alyssa O Trias, et al.
Pageof 4

Showing results (21-30 of 33) with videos related to

Sort By:
Pageof 4
Molecular Cancer Therapeutics|October 28, 2010
Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal modelsCurtis B Thompson, H Michael Shepard, Patrick M O'Connor, et al.
British Journal of Cancer|January 24, 2018
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Oncotarget|November 26, 2019
The growth of a xenograft breast cancer tumor model with engineered hyaluronan-accumulating stroma is dependent on hyaluronan and independent of CD44Chunmei Zhao, Benjamin J Thompson, Kelly Chen, et al.
British Journal of Cancer|September 27, 2017
Phase 1 trials of PEGylated recombinant human hyaluronidase PH20 in patients with advanced solid tumoursJeffrey R Infante, Ronald L Korn, Lee S Rosen, et al.
Biomed Research International|August 23, 2014
Accumulation of extracellular hyaluronan by hyaluronan synthase 3 promotes tumor growth and modulates the pancreatic cancer microenvironmentAnne Kultti, Chunmei Zhao, Netai C Singha, et al.
Molecular Cancer Therapeutics|October 15, 2008
Human epidermal growth factor receptor (HER-1:HER-3) Fc-mediated heterodimer has broad antiproliferative activity in vitro and in human tumor xenograftsJay Sarup, Pei Jin, Lisa Turin, et al.
JCI Insight|November 2, 2019
Multiple cancer-specific antigens are targeted by a chimeric antigen receptor on a single cancer cellYanran He, Karin Schreiber, Steven P Wolf, et al.
Biophysical Journal|May 12, 2016
Interstitial Pressure in Pancreatic Ductal Adenocarcinoma Is Dominated by a Gel-Fluid PhaseChristopher C DuFort, Kathleen E DelGiorno, Markus A Carlson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 28, 2016
Phase Ib Study of PEGylated Recombinant Human Hyaluronidase and Gemcitabine in Patients with Advanced Pancreatic CancerSunil R Hingorani, William P Harris, J Thaddeus Beck, et al.
Immunology|August 20, 2022
Targeting deoxycytidine kinase improves symptoms in mouse models of multiple sclerosisBao Ying Chen, Jessica R Salas, Alyssa O Trias, et al.
Pageof 4